According to Alexandria Real Estate Equities 's latest financial reports the company's current revenue (TTM) is $2.96 B. In 2022 the company made a revenue of $2.59 B an increase over the years 2021 revenue that were of $2.11 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.89 B | 11.85% |
2022 | $2.59 B | 22.44% |
2021 | $2.11 B | 12.34% |
2020 | $1.88 B | 23.03% |
2019 | $1.53 B | 15.36% |
2018 | $1.32 B | 17.67% |
2017 | $1.12 B | 25.64% |
2016 | $0.89 B | 9.56% |
2015 | $0.81 B | 13.76% |
2014 | $0.72 B | 16.18% |
2013 | $0.62 B | 3.23% |
2012 | $0.60 B | 20.35% |
2011 | $0.49 B | 8.69% |
2010 | $0.45 B | 17.94% |
2009 | $0.38 B | 4.13% |
2008 | $0.37 B | 18.53% |
2007 | $0.31 B | 29.07% |
2006 | $0.24 B | 27.74% |
2005 | $0.19 B | 23.82% |
2004 | $0.15 B | 16.31% |
2003 | $0.13 B | 13.39% |
2002 | $0.11 B | 18.74% |
2001 | $98.66 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 1,871.68% | ๐บ๐ธ USA |
Eli Lilly LLY | $35.93 B | 1,111.12% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 850.16% | ๐บ๐ธ USA |
Gilead Sciences GILD | $27.11 B | 813.93% | ๐บ๐ธ USA |
Illumina ILMN | $4.50 B | 51.81% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.53 B | 1,434.75% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $2.00 B | -32.48% | ๐บ๐ธ USA |